Hematologists’ barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study

BACKGROUND: Novel therapies often fail to reach the bedside due to low trial recruitment rates. Prior to conducting one of the first chimeric antigen receptor (CAR) T cell therapy trials in Canada, we used the Theoretical Domains Framework, a novel tool for identifying barriers and enablers to behav...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Castillo, Gisell, Lalu, Manoj, Asad, Sarah, Foster, Madison, Kekre, Natasha, Fergusson, Dean, Hawrysh, Terry, Atkins, Harold, Thavorn, Kednapa, Montroy, Joshua, Schwartz, Stuart, Holt, Robert, Broady, Raewyn, Presseau, Justin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7995587/
https://ncbi.nlm.nih.gov/pubmed/33766105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-021-05121-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados